Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — December 2020

Planlagt Fastgjort Låst Flyttet Genmab
1.1k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • BulderB Offline
    BulderB Offline
    Bulder
    wrote on sidst redigeret af
    #143

    Helge, er Epco på søndag ikke kl 21.30 da tid? 9.30 ville jo være midt om natten PST. Ikke fordi tidspunktet er afgørende, da der vist ikke er offentlig adgang, men vi skal nok ikke forvente kommentarer på Twitter eller en youtube-version før sent om aftenen.

    1 Reply Last reply
    0
    • D Offline
      D Offline
      Doublo
      wrote on sidst redigeret af
      #144

      Zackb det mangler jeg også, en af de mest irriterende fejl på Google er, at gamle opslag ikke slettes, så der kommer et utal af gamle kursmål op når man søger. Jeg har dog både set 2700 og 3000 som kursmål.

      1 Reply Last reply
      0
      • BulderB Offline
        BulderB Offline
        Bulder
        wrote on sidst redigeret af
        #145

        Jeg har lagt et excel-ark op i debatten med de kursmål, jeg ligger inde med.

        1 Reply Last reply
        0
        • P Offline
          P Offline
          peter12
          wrote on sidst redigeret af
          #146

          Lidt mere om vores ven https://www.tmc.edu/news/2020/01/meet-2019-stat-wunderkind-limo-chen-ph-d-of-md-anderson-cancer-center/

          1 Reply Last reply
          0
          • BulderB Offline
            BulderB Offline
            Bulder
            wrote on sidst redigeret af
            #147

            Ja, her gentager han det med PD-(L)1 og CD38. Spørgsmålet er om han har arbejdet videre med det.

            1 Reply Last reply
            0
            • BulderB Offline
              BulderB Offline
              Bulder
              wrote on sidst redigeret af
              #148

              Sanofi kører et studie i Isatuximab + Cemiplimab mod bl.a. NSCLC. Winkel har tidligere sagt, at de vil afvente resultater fra dette studie, før der tages stilling til en evt. genoptagelse af daratumumab i solide.
              https://www.clinicaltrials.gov/ct2/show/NCT03367819?term=isatuximab+solid+tumor&draw=2&rank=1

              1 Reply Last reply
              0
              • P Offline
                P Offline
                peter12
                wrote on sidst redigeret af
                #149

                Jeg ved ikke om dette har været linket før https://clincancerres.aacrjournals.org/content/26/9/2203

                1 Reply Last reply
                0
                • BulderB Offline
                  BulderB Offline
                  Bulder
                  wrote on sidst redigeret af
                  #150

                  Det interessante ved sanofi's studie er, at det kører uden dexamethason (ser det ud til), som Winkel i sin tid udpegede som den mulige skurk i fadæsen.

                  1 Reply Last reply
                  0
                  • BulderB Offline
                    BulderB Offline
                    Bulder
                    wrote on sidst redigeret af
                    #151

                    JNJ-7957 er det samme som teclistamab. peter's link er det prækliniske studie, som har ført videre til klinisk studie i dara+teclistamab i MM https://www.clinicaltrials.gov/ct2/show/NCT04108195?term=daratumumab+teclistamab&draw=2&rank=1

                    1 Reply Last reply
                    0
                    • BulderB Offline
                      BulderB Offline
                      Bulder
                      wrote on sidst redigeret af
                      #152

                      Hvis Genmab/Janssen beslutter sig for at prøve igen med CD38 som mål for angreb på solide, bliver det nok ikke med dara men Hexabody cd38.

                      1 Reply Last reply
                      0
                      • G Offline
                        G Offline
                        GeorgeBest
                        wrote on sidst redigeret af
                        #153

                        Var det leukemi udover MM som de ville afprøve hexa-cd38 imod?

                        1 Reply Last reply
                        0
                        • BulderB Offline
                          BulderB Offline
                          Bulder
                          wrote on sidst redigeret af
                          #154

                          Fra aftalen med Janssen: HexaBody-CD38 could be superior to daratumumab for certain tumor cell types and may expand and extend the promise of CD38-targeted therapies for more patients with multiple myeloma, lymphoma, leukemia, and potentially beyond.

                          1 Reply Last reply
                          0
                          • BulderB Offline
                            BulderB Offline
                            Bulder
                            wrote on sidst redigeret af
                            #155

                            https://ir.genmab.com/news-releases/news-release-details/genmab-signs-agreement-janssen-next-generation-cd38-antibody/

                            1 Reply Last reply
                            0
                            • BulderB Offline
                              BulderB Offline
                              Bulder
                              wrote on sidst redigeret af
                              #156

                              "beyond" kunne jo være solide?

                              1 Reply Last reply
                              0
                              • G Offline
                                G Offline
                                GeorgeBest
                                wrote on sidst redigeret af
                                #157

                                Ja klart

                                1 Reply Last reply
                                0
                                • SolsenS Offline
                                  SolsenS Offline
                                  Solsen
                                  wrote on sidst redigeret af
                                  #158

                                  Hexa38 har præklinisk vist rigtig god effekt i DLBCL. Epco er også god her, men ellers en meget svær sygdom at kæmpe imod.

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #159

                                    https://twitter.com/HenrychihangFu1/status/1335039190845845504

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #160

                                      Dr Mark Wildgust: Updated APOLLO Trial Results Confirm Daratumumab Safety in Multiple Myeloma https://www.ajmc.com/view/dr-mark-wildgust-updated-apollo-trial-results-confirm-daratumumab-safety-in-multiple-myeloma - ONLY
                                      5% of patients had infusion-related reactions in the APOLLO study, and all of those were grade 1/grade 2. So real confirmation that subcu dara is well tolerated.

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #161

                                        https://genmab-at-ash-2020.com/ genmab-at-ash-2020

                                        1 Reply Last reply
                                        0
                                        • E Offline
                                          E Offline
                                          E_L
                                          wrote on sidst redigeret af
                                          #162

                                          a bit strange when you look at the pipeline, poster on the right or https://virtualboothdemo.s3.amazonaws.com/Genmab/Content/PDFs/ash/I FINAL PIPELINE.pdf , it shows HexaBody CD38 in development phase I/II

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger